Alpa Laboratories approves unaudited standalone consolidated financial results for Q2FY27 and H1FY27
BSE India
Alpa Laboratories board approves the unaudited standalone consolidated financial results for the quarter and half year ended September 30, 2026. The announcement includes the limited review report from the statutory auditor. No specific financial figures or segmental drivers are provided in the current filing.
| Sep 2026 | Jun 2026 | Sep 2025 | QoQ% | YoY% | |
|---|---|---|---|---|---|
| Revenue/Sales | 30.98 | 23.93 | 26.26 | 29.44% | 17.97% |
| EBITDA | -0.99 | 1.81 | 0.82 | -154.56% | -220.74% |
| Op. profit margin(%) | -7.18 | -16.54 | -8.54 | 56.59% | 15.92% |
| Net Profit | -1.85 | 0.98 | 0.11 | -288.27% | -1740.36% |
| EPS | -0.85 | 0.49 | 0.05 | -273.47% | -1800.00% |
* Consolidated data